Eradication of a large MOPC-315 tumor in athymic nude mice by chemoimmunotherapy with Lyt2+ splenic T cells from melphalan-treated BALB/c mice bearing a large MOPC-315 tumor.

Eradication of a large MOPC-315 tumor in athymic nude mice by chemoimmunotherapy with Lyt2+ splenic T cells from melphalan-treated BALB/c mice bearing a large MOPC-315 tumor. Cancer Immunol Immunother. 1990; 31(3):129-38.

View in: PubMed

subject areas

Animals
Antigens, Differentiation, T-Lymphocyte
Combined Modality Therapy
Dose-Response Relationship, Drug
Immunization, Passive
Immunotherapy
Melphalan
Mice
Mice, Inbred BALB C
Mice, Nude
Neoplasms, Experimental
Plasmacytoma
Spleen
Survival Analysis
T-Lymphocytes

authors with profiles

Ed Barker